Clinical trial NCT05182697
Status: RecruitingNo phase (not a drug trial)Latest change: Source: ClinicalTrials.gov
What's on this page?
Information in the record
Original title: SCI-210 in the Treatment of Children and Young Adults With AutismEvaluate the Safety, Tolerability and Efficacy of SCI-210 in Children With Autism Spectrum Disorder (ASD)
- Record number
- NCT05182697
- Status
- Recruiting
- Type and phase
- Clinical trial, no phase (not a drug trial)
- Participants
- Target: 60
- Condition (as registered)
- Autism Spectrum Disorder (ASD)
- Countries
- Israel
- Topic in the guide
- Autism
Timeline
According to the ClinicalTrials.gov record. Future dates are the investigator’s estimates and may change.
- Start: February 21, 2024
- End of data collection for primary results: May 2026
- Trial completion: June 2026
History
We check the record every day; here are the changes we have seen since we started tracking it, newest first.
- : Added to tracking. Status: Recruiting.
Results
No results have been published yet. When they are, they will appear here. A trial being under way does not mean CBD works for this condition; only the results can show that.
All ongoing trials · Autism: ongoing trials · Thinking of taking part? Which specialist to see